Michelle A. Fanale
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 207
- Oncology top 0.5%
- Viral-associated cancers and disorders 52
- CAR-T cell therapy research 46
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 60
- Dermatology top 0.5%
- Cutaneous lymphoproliferative disorders research 27
- Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 38
-
- Lung Cancer Treatments and Mutations 28
-
- Monoclonal and Polyclonal Antibodies Research 23
- Co-authors
- Anas YounesRanjana H. AdvaniNancy L. BartlettBarbara ProDana A. KennedyJoseph D. RosenblattRadhakrishnan RamchandrenAndrei R. Shustov
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michelle A. Fanale
239 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pathology and Forensic Medicine 4.1k
- Oncology 3.9k
- Genetics 1.2k
- Dermatology 734
- Neurology 1.2k
Countries citing papers authored by Michelle A. Fanale
This map shows the geographic impact of Michelle A. Fanale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Fanale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Fanale more than expected).
Fields of papers citing papers by Michelle A. Fanale
This network shows the impact of papers produced by Michelle A. Fanale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Fanale. The network helps show where Michelle A. Fanale may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michelle A. Fanale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 | |
| 6 | Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trialbreakdown → | 2018 | 455 |
| 7 | 2018 | 96 | |
| 8 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphomabreakdown → | 2017 | 694 |
| 9 | 2017 | 22 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 1 | |
| 15 | 2016 | 9 | |
| 16 | 2015 | 68 | |
| 17 | 2014 | 10 | |
| 18 | 2014 | 19 | |
| 19 | 2012 | 34 | |
| 20 | 2011 | 160 |
About Michelle A. Fanale
Michelle A. Fanale is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 252 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (207 papers), Chronic Lymphocytic Leukemia Research (60 papers), Viral-associated cancers and disorders (52 papers), CAR-T cell therapy research (46 papers), CNS Lymphoma Diagnosis and Treatment (38 papers), Lung Cancer Treatments and Mutations (28 papers), Cutaneous lymphoproliferative disorders research (27 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.1k citations), Oncology (3.9k citations) and Genetics (1.2k citations). Michelle A. Fanale has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Anas Younes, Ranjana H. Advani, Nancy L. Bartlett, Barbara Pro, Dana A. Kennedy, Joseph D. Rosenblatt, Radhakrishnan Ramchandren, Andrei R. Shustov, Joseph M. Connors and Luis Fayad. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.